The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...

Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

The president-elect might bring back efforts to make other countries pay more for drugs, but there are pitfalls.

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

College costs have been on a mostly upward trend for the last two decades. In addition to rising tuition prices, paying for housing, food, transportation, textbooks and other school-related fees ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...